Support Alert

Class 3 Medicines Recall: Advanz Pharma, Carbimazole 10mg and 15mg tablets

Advanz Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling batches of carbimazole tablets due to an out of specification observation for tablet appearance of samples during routine stability testing.

Further information including details of the affected batches, a brief description of the problem and advice for healthcare professionals can be found on the MHRA website.


Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.